Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Garmo

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
British Journal of Cancer|February 2, 2013
Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised studyL Holmberg, Y N S Wong, L Tabár, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2008
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancerB Glimelius, H Sørbye, L Balteskard, et al.
Statistics in Medicine|February 25, 2017
A latent class model for competing risksM Rowley, H Garmo, M Van Hemelrijck, et al.
International Journal of Cancer|January 12, 2018
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS studyR Arthur, R Williams, H Garmo, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2006
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trialA Ringberg, H Nordgren, S Thorstensson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2014
Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationshipA Purushotham, E Shamil, M Cariati, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countriesG George, D Enting, H Garmo, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
British Journal of Cancer|February 2, 2013
Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised studyL Holmberg, Y N S Wong, L Tabár, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2008
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancerB Glimelius, H Sørbye, L Balteskard, et al.
Statistics in Medicine|February 25, 2017
A latent class model for competing risksM Rowley, H Garmo, M Van Hemelrijck, et al.
International Journal of Cancer|January 12, 2018
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS studyR Arthur, R Williams, H Garmo, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2006
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trialA Ringberg, H Nordgren, S Thorstensson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2014
Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationshipA Purushotham, E Shamil, M Cariati, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countriesG George, D Enting, H Garmo, et al.
Pageof 3